未登录

U

Umar Raza

Guangdong Medical University

H指数:16

被引数:1,349

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tackling cancer stemness with nanotechnology in the era of precision medicine

在精准医学时代利用纳米技术应对癌症干性

IF15.5

2026-01-010

OAAI

On the Difference of Coefficients of Class U(α, A)

关于类U(α, A)系数的差异

BULLETIN OF THE MALAYSIAN MATHEMATICAL SCIENCES SOCIETY

IF0

2025-09-030

PRE

From bench to bedside: Advancing towards therapeutic treatment of vestibular schwannomas

从工作台到床边: 前庭神经鞘瘤的治疗进展

NEURO-ONCOLOGY ADVANCES

IF4.1

2024-06-240

OAAI

Hypoxia-driven ncRNAs in breast cancer

FRONTIERS IN ONCOLOGY

IF3.3

2023-07-312

OAAI

KIN17 promotes cell migration and invasion through stimulating the TGF-β/Smad2 pathway in hepatocellular carcinoma

MOLECULAR CARCINOGENESIS

IF3.2

2022-12-059

PRE

Neutrophils: Musketeers against immunotherapy

FRONTIERS IN ONCOLOGY

IF3.3

2022-08-2520

OAAI

Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases

Alpha-1-antichymotrypsin作为人类疾病诊断，预后和治疗预测的新型生物标志物

CANCER CELL INTERNATIONAL

IF6

2022-04-1932

OAAI

Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer

BREAST CANCER RESEARCH AND TREATMENT

IF3

2022-03-2531

OA

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer

NATURE COMMUNICATIONS

IF15.7

2020-05-15222

OAAI

Pathobiology of pulmonary artery hypertension: role of long non-coding RNAs

CARDIOVASCULAR RESEARCH

IF13.3

2020-02-2839

OAAI

mTOR/HDAC1 Crosstalk Mediated Suppression of ADH1A and ALDH2 Links Alcohol Metabolism to Hepatocellular Carcinoma Onset and Progression in silico

FRONTIERS IN ONCOLOGY

IF3.3

2019-10-0422

OAAI

Systems biology based meth-miRNA-mRNA regulatory network identifies metabolic imbalance and hyperactive cell cycle signaling involved in hepatocellular carcinoma onset and progression

CANCER CELL INTERNATIONAL

IF6

2019-04-087

OAAI

Novel tumor suppressor SPRYD4 inhibits tumor progression in hepatocellular carcinoma by inducing apoptotic cell death

新型肿瘤抑制因子SPRYD4通过诱导凋亡细胞死亡抑制肝细胞癌的肿瘤进展

CELLULAR ONCOLOGY

IF4.8

2018-09-2013

PREAI

Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer

CLINICAL CANCER RESEARCH

IF10.2

2018-04-1246

OAAI

Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells

CANCER RESEARCH

IF16.6

2018-04-0188

OAAI

Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer

IF7.3

2018-02-0259

PREAI

Identifying and targeting competing endogenous RNA (ceRNAs) networks to inhibit lung metastasis in triple negative breast cancer

CANCER RESEARCH

IF16.6

2017-07-010

PRE

miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer

SCIENTIFIC REPORTS

IF3.9

2016-09-0763

OAAI

Combinatorial targeting of PI3K and MAPK signaling pathways using microRNAs to inhibit tumor growth and metastasis in breast cancer

CANCER RESEARCH

IF16.6

2016-07-151

PRE

Combinatorial targeting of PI3K and MAPK signaling pathways using microRNAs to inhibit cell proliferation and invasion in breast cancer

EUROPEAN JOURNAL OF CANCER

IF7.1

2016-07-010

PREAI